TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32928560

Group type: EXPERIMENTAL
Intervention: Quercetin 75 μg/ml (Q75)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Quercetin 150 μg/ml (Q150)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Quercetin 300 μg/ml (Q300)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Sodium fluoride (NaF)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control (deionized water, ethanol, chlorhexidine, EGCG)
Number of subjects: 212
Study: 33413030

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33979577

Group type: EXPERIMENTAL
Intervention: Glass hybrid (GH; EQUIA Forte Fil/EQUIA Forte Coat)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Resin composite (RC; OptiBond FL/Filtek Supreme XTE)
Number of subjects: 88
Study: 32122219

Group type: EXPERIMENTAL
Intervention: Anakinra once daily (N=33)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Anakinra twice daily (N=31)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Anakinra (both dosing regimens combined)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (N=35)
Number of subjects: 99
Study: 35470813

Group type: EXPERIMENTAL
Intervention: Stepped-care cognitive behavioral therapy for tinnitus
Number of subjects: 403
Study: 33545015

Group type: EXPERIMENTAL
Intervention: Hexavalent rotavirus vaccine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo 1
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo 2
Number of subjects: 200
Study: 32684465

Group type: EXPERIMENTAL
Intervention: 0.3% purple corn pigment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without purple corn pigment)
Number of subjects: 0
Study: 35768167

Group type: EXPERIMENTAL
Intervention: SCPB with 10 mL of 0.5% ropivacaine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control with 0.9% normal saline
Number of subjects: 106
Study: 33938829

Group type: EXPERIMENTAL
Intervention: Ringer Lactate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Plasmalyte‐A
Number of subjects: 80
Study: 32331033

Group type: EXPERIMENTAL
Intervention: Dasotraline 6 mg/d
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Dasotraline 4 mg/d
Number of subjects: 486

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 486
Study: 616083736

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (1.25 mg/0.05 mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-dose bevacizumab (0.625 mg/0.025 mL) combined with low-dose triamcinolone (1 mg/0.025 mL)
Number of subjects: 40
Study: 35089202

Group type: EXPERIMENTAL
Intervention: Nebulized fentanyl citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 34810296

Group type: EXPERIMENTAL
Intervention: TJP-008 (1-day split dose)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: TJP-008 (2-day split dose)
Number of subjects: 293

Group type: COMPARATOR
Intervention: 2L PEG with ascorbate (2-day split dose)
Number of subjects: 293
Study: 32253388

Group type: EXPERIMENTAL
Intervention: Television distraction
Number of subjects: 69

Group type: COMPARATOR
Intervention: Tell-Show-Do (TSD)
Number of subjects: 69
Study: 35196481

Group type: EXPERIMENTAL
Intervention: Sunbeam program (two 1-hour sessions/week of tailored and progressive resistance and balance training for 25 weeks followed by two 30-min sessions/week of nonprogressive exercise for 6 months)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Sunbeam program
Number of subjects: 148

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 148
Study: 33150732

Group type: EXPERIMENTAL
Intervention: Tailored habituation protocol for MRI including gradual exposure to scanner noise, social stories booklet, positive incentive strategies, and Play Therapy support
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Tailored habituation protocol for MRI
Number of subjects: 31
Study: 33983868

Group type: EXPERIMENTAL
Intervention: COVID-19 patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 45
Study: 32044802

Group type: EXPERIMENTAL
Intervention: Anterior suprascapular block with 15 ml of ropivacaine 0.5% and epinephrine
Number of subjects: 140

Group type: COMPARATOR
Intervention: Interscalene block with 15 ml of ropivacaine 0.5% and epinephrine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Combined superior trunk (C5‐C6 dermatomes) blockade
Number of subjects: 140
Study: 36239376

Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT) training
Number of subjects: 52

Group type: COMPARATOR
Intervention: Tied-Belt Treadmill (TBT) training
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT) training and Tied-Belt Treadmill (TBT) training
Number of subjects: 52
Study: 33441355

Group type: EXPERIMENTAL
Intervention: SPA intervention (10 weekly singing group sessions led by a music facilitator)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: SPA intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (aphasia information resource pack)
Number of subjects: 41
Study: 35926824

Group type: EXPERIMENTAL
Intervention: GSP301 nasal spray (olopatadine hydrochloride 665 μg and mometasone furoate 25 μg), 1 spray/each nostril twice daily for 14 days
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: GSP301 nasal spray
Number of subjects: 446

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 446
Study: 34282929

Group type: EXPERIMENTAL
Intervention: Mycelial plugs (5 mm diameter) from Sclerotinia isolates SN1 and SN2 inoculated on healthy ginseng roots.
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Negative control using PDA plugs without mycelia.
Number of subjects: 1000
Study: 34741249

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team (MDT) care
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: MDT care
Number of subjects: 140
Study: 35377820

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Stretching and toning (SAT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Personalized Mobile Trainer (PMT)
Number of subjects: 20
Study: 32011642

Group type: EXPERIMENTAL
Intervention: tPA and DNase (4 mg tPA and 5 mg DNase)
Number of subjects: 97

Group type: COMPARATOR
Intervention: tPA and placebo (5 mL normal saline)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: tPA and DNase
Number of subjects: 97

Group type: COMPARATOR
Intervention: tPA and placebo
Number of subjects: 97
Study: 35883930

Group type: EXPERIMENTAL
Intervention: Loaded functional strengthening exercises program using a shoe supporter to maintain a plantigrade foot position
Number of subjects: 72

Group type: COMPARATOR
Intervention: Specially designed physical therapy program
Number of subjects: 72
Study: 33338740

Group type: EXPERIMENTAL
Intervention: Guided self-disclosure intervention (GSDI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 36099189

Group type: EXPERIMENTAL
Intervention: Self-customized avatar condition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Assigned avatar condition
Number of subjects: 60
Study: 33950223

Group type: EXPERIMENTAL
Intervention: High intensity intervention targeting canteen managers
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Medium intensity intervention targeting canteen managers
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Low intensity intervention targeting canteen managers
Number of subjects: 162
Study: 32358310

Group type: EXPERIMENTAL
Intervention: Free weights
Number of subjects: 46

Group type: COMPARATOR
Intervention: Machines
Number of subjects: 46
Study: 35819944

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G (BPG)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Doxycycline (DOXY)
Number of subjects: 823
Study: 32572611

Group type: EXPERIMENTAL
Intervention: Nutritional counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Respiratory counseling
Number of subjects: 0
Study: 32723114

Group type: EXPERIMENTAL
Intervention: Amplatz renal dilator
Number of subjects: 88

Group type: COMPARATOR
Intervention: Visual internal urethrotomy (cold knife)
Number of subjects: 88
Study: 34113095

Group type: EXPERIMENTAL
Intervention: Nemiralisib 750 µg
Number of subjects: 938

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Nemiralisib (all doses)
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Nemiralisib
Number of subjects: 938
Study: 32126995

Group type: EXPERIMENTAL
Intervention: Dynamic Locking Blade Plate (DLBP)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 266
Study: 33205847

Group type: EXPERIMENTAL
Intervention: Robot group (RG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Free-hand group (FG)
Number of subjects: 56
Study: 32028795

Group type: EXPERIMENTAL
Intervention: Preheated chlorhexidine in 70% ethanol (36°C)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Room temperature chlorhexidine in 70% ethanol (20°C)
Number of subjects: 220
Study: 34325670

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 25mcg every 2 hours
Number of subjects: 520

Group type: COMPARATOR
Intervention: Intravenous oxytocin (titrated)
Number of subjects: 520
Study: 33006564

Group type: EXPERIMENTAL
Intervention: Attentive eating smartphone app
Number of subjects: 38
Study: 36171028

Group type: EXPERIMENTAL
Intervention: +Stay Active intervention (motivational interviewing combined with the Stay‐Active smartphone application)
Number of subjects: 60
Study: 34006551

Group type: EXPERIMENTAL
Intervention: Modified Tai Chi postural training (TPT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bobath rehabilitation training
Number of subjects: 120
Study: 32894238

Group type: EXPERIMENTAL
Intervention: ELDOA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Post-facilitation stretching
Number of subjects: 40
Study: 35220473

Group type: EXPERIMENTAL
Intervention: Melatonin (4 mg, n = 419)
Number of subjects: 841

Group type: COMPARATOR
Intervention: Placebo (n = 422)
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Melatonin (4 mg)
Number of subjects: 841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 841
Study: 32581009

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Statin
Number of subjects: 357

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 357
Study: 35639646

Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg twice/day) and folic acid (400 μg /day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Inofolic (inositol + olic acid 200 μg twice/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 80
Study: 32268118

Group type: EXPERIMENTAL
Intervention: 4-week alternate day fasting (ADF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Long-term fasters
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 34418398

Group type: EXPERIMENTAL
Intervention: Bexarotene (300 mg/m2 per day for 6 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Bexarotene
Number of subjects: 52
Study: 36452175

Group type: EXPERIMENTAL
Intervention: ENTF therapy (1–100 Hz, < 1 G), 40 min active treatment 5 days/week for 8 weeks; 3 treatments accompanied by 10 min of concurrent physical/occupational therapy.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatment, 40 min treatment 5 days/week for 8 weeks.
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ENTF therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 21
Study: 32996128

Group type: EXPERIMENTAL
Intervention: Poly Lactic‐Co‐Glycolic Acid‐Coated β‐Tricalcium Phosphate (PLGA‐β‐TCP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Freeze‐dried bone allograft (FDBA) particles covered with a rapidly absorbable collagen dressing (RACD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups (PLGA‐β‐TCP and FDBA+RACD)
Number of subjects: 45
Study: 35441566

Group type: EXPERIMENTAL
Intervention: Tipping Point Program (TPP)
Number of subjects: 1275

Group type: EXPERIMENTAL
Intervention: Tipping Point Program Plus (TPP+)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1275
Study: 32531816

Group type: EXPERIMENTAL
Intervention: Snow mushroom hand sanitizer (10% snow mushroom extract, 66.5% ethanol, 0.3% triclosan)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo hand sanitizer
Number of subjects: 20
Study: 36205472

Group type: EXPERIMENTAL
Intervention: PHM intervention (N = 97)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC; N = 93)
Number of subjects: 190
Study: 32106807

Group type: EXPERIMENTAL
Intervention: High dose meropenem (3 g q8h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard dose meropenem (2 g q8h)
Number of subjects: 24
Study: 33305681

Group type: EXPERIMENTAL
Intervention: BCG therapy
Number of subjects: 4549

Group type: COMPARATOR
Intervention: Radical cystectomy (RC)
Number of subjects: 4549
Study: 34883088

Group type: EXPERIMENTAL
Intervention: Phenotype 1 (hypoinflammatory)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Phenotype 2 (hyperinflammatory)
Number of subjects: 304
Study: 34631289

Group type: EXPERIMENTAL
Intervention: Pulley Release
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pulley Reconstruction
Number of subjects: 40
Study: 36364809

Group type: EXPERIMENTAL
Intervention: Personalized vitamin D3 loading dose followed by daily 2000 IU
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 32041897

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CE) intervention for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-CE control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CE) intervention
Number of subjects: 0
Study: 36210321

Group type: EXPERIMENTAL
Intervention: Surgery with preoperative short-course radiotherapy
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Patients with complications
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Patients without complications
Number of subjects: 1207
Study: 33258284

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Positive Airway Pressure (PAP)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: MAD
Number of subjects: 180

Group type: COMPARATOR
Intervention: PAP
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: MAD and PAP
Number of subjects: 180
Study: 35063245

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Probiotic intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35667073

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intra-articular glucocorticoid injection
Number of subjects: 0
Study: 32236353

Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG) with Coronally Advanced Flap (CAF)
Number of subjects: 19
Study: 34536606

Group type: EXPERIMENTAL
Intervention: PUI/NaOCl
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PUI/solvent
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SWEEPS®/NaOCl
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SWEEPS®/solvent
Number of subjects: 48
Study: 32422597

Group type: EXPERIMENTAL
Intervention: Fitness tracker with daily step target for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fitness tracker without specific step goals for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group documenting physical activity
Number of subjects: 0
Study: 33959920

Group type: EXPERIMENTAL
Intervention: Opioid pain medication
Number of subjects: 381

Group type: COMPARATOR
Intervention: Non-opioid pain medication
Number of subjects: 381

Group type: COMPARATOR
Intervention: No pain medication
Number of subjects: 381
Study: 33213413

Group type: EXPERIMENTAL
Intervention: Arts-based intervention (six one-hour, one-to-one facilitated arts sessions during haemodialysis)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (standard care during haemodialysis)
Number of subjects: 24
Study: 34176234

Group type: EXPERIMENTAL
Intervention: 2 days/week intermittent VLCD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4 days/week intermittent VLCD
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34624665

Group type: EXPERIMENTAL
Intervention: Affective working memory training (aWMT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Neutral working memory training (nWMT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 60
Study: 36509948

Group type: EXPERIMENTAL
Intervention: Internal traction method‐assisted STER (study group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional STER (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 35559507

Group type: COMPARATOR
Intervention: Normoxia (Fi O2 = 20.6 ± 0.3%)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hypoxia (Fi O2 = 14.0 ± 0.2%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 21
Study: 36148979

Group type: EXPERIMENTAL
Intervention: General Anesthesia (Group GA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia with General Anesthesia (Group SGA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both Groups (GA and SGA)
Number of subjects: 40
Study: 32762505

Group type: EXPERIMENTAL
Intervention: Apple vinegar (AV) - 10 ml diluted in 200 ml drinking water with breakfast and dinner for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study: 35320488

Group type: EXPERIMENTAL
Intervention: Omentopexy (underwent LSG with omentopexy)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Non-omentopexy (underwent LSG only)
Number of subjects: 91
Study: 32659029

Group type: EXPERIMENTAL
Intervention: Intraspecific hybrid population (HEB‐25)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identified candidate gene REC8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wild barley introgression patterns
Number of subjects: 0
Study: 34503428

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids supplementation (oral, based on children's weight for three consecutive days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard antibiotic treatment only
Number of subjects: 60
Study: 32131885

Group type: EXPERIMENTAL
Intervention: Daily use of lipid-rich emollient
Number of subjects: 625

Group type: COMPARATOR
Intervention: No emollient (control)
Number of subjects: 625
Study: 35778655

Group type: EXPERIMENTAL
Intervention: Hybrid Mindful Awareness Practices (MAPs) intervention, comprised of one in-person 60–min session and 6-week access to a digitally delivered MAPs curriculum (n = 27)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Wait-list control (n = 39)
Number of subjects: 66
Study: 32277809

Group type: EXPERIMENTAL
Intervention: Clofazimine (CFZ)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Part B controls (HIV without cryptosporidiosis)
Number of subjects: 20
Study: 32800328

Group type: EXPERIMENTAL
Intervention: Proactive protection motivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Passive protection motivation
Number of subjects: 0
Study: 34253089

Group type: EXPERIMENTAL
Intervention: Videos with medical footage and sad stories (unresolved or mourning)
Number of subjects: 1696

Group type: COMPARATOR
Intervention: Videos with medical footage and uplifting story
Number of subjects: 1696
Study: 34708705

Group type: EXPERIMENTAL
Intervention: Pentazocine + Diclofenac
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paracetamol + Diclofenac
Number of subjects: 100
Study: 34281934

Group type: COMPARATOR
Intervention: Control (sham intervention)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Direct swallowing training (DST)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Direct swallowing training + oral sensorimotor stimulation (DST+OSMS)
Number of subjects: 186
Study: 32248906

Group type: EXPERIMENTAL
Intervention: LVOTAbiplane (direct planimetry)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: LVOTAbiplane
Number of subjects: 134
Study: 36410494

Group type: EXPERIMENTAL
Intervention: Nebulized TA (500 mg tid)
Number of subjects: 110

Group type: COMPARATOR
Intervention: IV TA (500 mg tid)
Number of subjects: 110
Study: 33656085

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 0
Study: 35416437

Group type: EXPERIMENTAL
Intervention: Qingjin Yiqi granules (QJYQ) combined with standard rehabilitation treatments (SRTs)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Control group (only received SRTs)
Number of subjects: 388
Study: 34530402

Group type: EXPERIMENTAL
Intervention: EMFSTC (n = 15, 16-week practice)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (n = 16, no practice)
Number of subjects: 31
Study: 32157434

Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of tramadol (2 mg/kg)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of ketamine (0.5 mg/kg)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo (3 mL of peritonsillar saline)
Number of subjects: 107
Study: 34415081

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) to the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study: 36436732

Group type: EXPERIMENTAL
Intervention: Substance Use Skills Training and Exposure Post-Sexual Assault (STEPS) intervention
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ecological momentary assessments
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: STEPS intervention
Number of subjects: 54